BioSpace News Archive

As the global community continues its fight to contain the 2019 Novel Coronavirus (COVID-19) pandemic, SC Johnson today announced a $1 million contribution to the CDC Foundation’s Emergency Response Fund to strengthen domestic and global public health infrastructure and responses to address the spread of COVID-19.

Toxys is an innovative Dutch biotech company that develops unique animal-free laboratory tests for the safety assessment of novel medicines, chemicals, cosmetics and food. Today, Toxys announces a €2 million funding round from KIKK Capital, InnovationQuarter, Zeeland Investment fund, Toxys management and Rabobank.

What can the public do to defend against the COVID-19 coronavirus? One simple answer is to ramp up humidification at home and in the workplace, if humidity levels are low.

Zelluna Immunotherapy, a biopharma company pioneering the use of T cell receptor (TCR) guided Natural Killer (NK) cell therapy products for the treatment of multiple solid cancers, and the world renowned Karolinska Institutet (KI) in Stockholm, Sweden, today announce a collaboration to develop next generation TCR-NK products for the treatment of patients with solid cancers.

The Elie Hirschfeld Foundation announces a multi-faceted effort to aid the region’s response to the rapidly growing crisis created by the novel Coronavirus COVID-19.

Sensorion announced today an update on timelines for the ongoing Phase 2 study of SENS-401 to treat Sudden Sensorineural Hearing Loss (SSNHL). Patient recruitment rates from this trial now indicate

A Queensland-based software developer has offered to help the federal government with its aim of delivering a system that will enable patients to have prescriptions completed and filed electronically with a nearby pharmacy and home delivered, all without the patient having to leave their home.

Methodist Le Bonheur Healthcare announced additional precautions aimed at better protecting the safety of its patients, Associates and others in our community.

Zyla Life Sciences, a commercial stage life sciences company, announced that its year end 2019 financial results will be released on March 27, 2020.

Verrica Pharmaceuticals Inc., a dermatology therapeutics company developing medications for viral skin diseases requiring medical interventions, announced financial results for the fourth quarter ended December 31, 2019.